Clinical Trial Update: Effect of Intravenous FerRic carbOxymaltose oN Reverse Remodeling Following Cardiac Resynchronization Therapy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effect of intravenous ferric carboxymaltose on reverse remodeling after cardiac resynchronization therapy in heart failu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• intravenous ferric carboxymaltose (ferric carboxymaltose)

Snippet

Sponsor: Hasselt University | Conditions: Heart Failure | Phase 4 | Status: COMPLETED